Dermata Therapeutics, Inc (DRMA) insider trading

Every open-market stock purchase and sale by Dermata Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders sold $13 over the last 12 months (1 sale).
  • Last insider buy: Munera Maria E Bedoya-Toro (VP), $1.3K, 7 months ago.

Last 12 months: insiders bought $1.3K (1 buy) and sold $13 (1 sale). Last close $1.18 on Jun 4, 2026.

Recent DRMA insider trades

DateInsiderTradeValue
Jun 16, 2026Kathleen D. Scott (Director)Sold$13
Feb 17, 2026Munera Maria E Bedoya-Toro (VP)Bought$1.3K
Jan 2, 2026Andrew Seth Sandler (Director)Bought (not open market)—
Jan 2, 2026Kathleen D. Scott (Director)Bought (not open market)—
Jan 2, 2026David F Hale (Director)Bought (not open market)—
Jan 2, 2026Kyri K. Van Hoose (CFO)Bought (not open market)—
Jan 2, 2026Wendell Wierenga (Director)Bought (not open market)—
Jan 2, 2026Mary Fisher (Director)Bought (not open market)—
Jan 2, 2026Brittany Bradrick (Director)Bought (not open market)—
Jan 2, 2026Gerald T Proehl (CEO)Bought (not open market)—
Jan 2, 2026Christopher J. Nardo (C-suite exec)Bought (not open market)—
Jan 2, 2026Munera Maria E Bedoya-Toro (VP)Bought (not open market)—
Jan 2, 2026Steven J Mento (Director)Bought (not open market)—
Dec 23, 2025Gerald T Proehl (CEO)Bought (not open market)$1M
Dec 23, 2025Gerald T Proehl (CEO)Sold (not open market)$1M
Dec 23, 2025Gerald T Proehl (CEO)Bought (not open market)$250K
Dec 23, 2025Kyri K. Van Hoose (CFO)Bought (not open market)$250K
Dec 23, 2025Gerald T Proehl (CEO)Bought (not open market)$161K
Dec 23, 2025Kyri K. Van Hoose (CFO)Sold (not open market)$100K
Dec 23, 2025Kyri K. Van Hoose (CFO)Bought (not open market)$16.1K

Who's trading DRMA

Get free alerts when an insider at Dermata Therapeutics, Inc files a new trade →